Nominate a North Texas Leader for the Dennis K. Stone Award

BioNTX honors individuals who have made significant contributions to the North Texas biotechnology industry through the Dennis K. Stone Award. This recognition celebrates those who have advanced life science research and inspired others to do the same.

Nominees should meet the following criteria:

• Industry Growth & Innovation: Contributed to the formation and growth of multiple North Texas-based life science businesses.

• Generosity: Donated time, resources, or funds to support the North Texas life science community.

• Mentorship & Inspiration: Inspired and mentored others, fostering the continued growth of the North Texas life science industry.

• Regional Advocacy: Actively championed the region as a thriving hub for successful life science ventures.

Past recipients of the Dennis Stone Award
(originally known as the Double Helix Award):

Who was Dennis K. Stone?

Dennis K. Stone was an accomplished scientist and an instrumental figure in biotechnology developments and advancements at UT Southwestern and in the Dallas-Fort Worth area.

Among his many accomplishments, Dr. Stone led UT Southwestern Medical Center’s Office for Technology Development and launched its BioCenter at Southwestern Medical District. Of his many contributions, Dr. Stone is remembered by colleagues as ”having an infectious enthusiasm and passion for the biotechnology industry”. This passion helped fuel the confidence of companies and investors and kicked off an emergence of the industry in North Texas.

Dennis Stone was born and raised in Dallas before receiving his undergraduate degree from UT Austin in 1973 and his medical degree from UT Southwestern in 1977. Following an internship and residency training at Columbia-Presbyterian, he obtained his postdoctoral training at UT Southwestern and Cornell University.

Dr. Stone joined the faculty of UT Southwestern as a member of the Nephrology Division of Internal Medicine and then became the Chief of the Division of Molecular Transport. He quickly ascended the academic ranks, becoming Professor of Internal Medicine, Physiology, and Biochemistry. He was the first Associate Dean for Medical Student Research and then was appointed Vice President of Technology Development (1998-2011).

In 2011, Dr. Stone left UT Southwestern to become the Chief Scientific Officer of Remeditex Ventures. Dr. Stone held this position from August 2011 to June 2016. During his time at Remeditex, he was involved in key investments into Texas-based companies such as Bellicum Pharmaceuticals and Peloton Therapeutics that not only were successful investments but also developed efficacious products that are either approved or in late stage clinical trials, benefitting patients across the globe.

The impact that Dr. Stone left on the DFW biotech industry is immeasurable. Dr. Stone’s legacy is carried on by his wife and colleague, Dr. Helen H. Hobbs, with whom he shared a strong commitment for the UT Southwestern mission. “Dennis was committed to the development of biotechnology in Dallas both as a faculty member of UT Southwestern and after he left to join the venture capital firm of Remeditex.”